Skip to main content
. 2023 Jun 19;12(2):e002278. doi: 10.1136/bmjoq-2023-002278

Table 1.

Summary of TPS programme eligibility and data tracking outcome measures

Data tracking measure Number of patients
n (%); (95% CIs)
Eligibility criteria
Major
 OME >60–200 mg preoperatively 11
 On opioids alone 0
Minor
 1. On opioids >6 months preoperatively 30
 2. Taking ≥3 types of narcotics 2
 3. Prescribed long-acting opioid 13
 4. Self-reported fibromyalgia OR depression OR anxiety OR high emotional stress 25
Data tracking
Outcome of interest
OME
 Intake 26/26 (100); (0.87, 1.00)
 Discharge 26/26 (100); (0.87, 1.00)
VAS of perceived analgesic management
 Intake 24/26 (92.3); (0.75, 0.99)
 Discharge 24/26 (92.3); (0.75, 0.99)
VAS of overall health
 Intake 24/26 (92.3); (0.75, 0.99)
 Discharge 24/26 (92.3); (0.75, 0.99)
Resource utilisation
 LOS in hospital 26/26 (100); (0.87, 1.00)
 Appointment attendance 26/26 (100); (0.87, 1.00)
 ED return visit at 60 days 26/26 (100); (0.87, 1.00)

ED, emergency department; LOS, length of stay; OME, oral morphine equivalent; TPS, Transitional Pain Service; VAS, Visual Analogue Scale.